Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Voyager Therapeutics Inc chart...

About the Company

voyager therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (cns). voyager is committed to advancing the field of aav (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production. the company’s initial pipeline is focused on cns diseases in dire need of effective new therapies, including parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (als), and friedreich’s ataxia. founded by scientific and clinical leaders in the fields of aav gene therapy, expressed rna interference and neuroscience, voyager therapeutics was launched in 2014 with funding from leading life sciences investor third rock ventures and is headquartered in cambridge, mass. for more information, please visit www.voyagertherapeutics.com.

$342M

Total Revenue

149

Employees

$400M

Market Capitalization

6.46

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $VYGR News

Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer

6d ago, source:

LEXINGTON, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: VYGR), a biotechnology company dedicated to advancing ...

Voyager Therapeutics: On Track To Deliver High Returns On Investment

5d ago, source: Seeking Alpha

In this article, I will be providing a financial and scientific analysis of Voyager Therapeutics Inc. (NASDAQ:VYGR). Financially speaking, Voyager is still due to live up to its expectations ...

Voyager Therapeutics (NASDAQ: VYGR)

5d ago, source: The Motley Fool

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes ...

Voyager 1 is 15 billion miles from home and broken. Here's how NASA is trying to fix it.

1h ago, source:

Voyager 1, which left Earth 46 years ago, is now 15 billion miles away. NASA is sifting through computer codes and old ...

NASA scientist viewed first Voyager images. What he saw gave him chills.

on MSN ago, source:

In 1979, Alan Cummings, a scientist working on NASA's unprecedented Voyager mission, entered a Caltech room in Pasadena, ...

NASA gave Voyager 1 a 'poke' amid communication woes. Here's why the response was encouraging.

on MSN ago, source:

The mission of one of NASA's twin Voyager space probes has been in peril for months as the agency has been unable to receive ...

Aging Voyager 1 sends back surprising response after ‘poke’ from Earth

on MSN ago, source:

A “poke” sent to the Voyager 1 probe received a response that could help NASA restore reliable communication with the aging ...

Finally, engineers have a clue that could help them save Voyager 1

3d ago, source:

Suzanne Dodd, NASA's project manager for Voyager 1 and its twin, Voyager 2, recently told Ars that engineers would need to ...

Voyager Therapeutics Appoints Toby Ferguson As Chief Medical Officer

5d ago, source:

Biotechnology company Voyager Therapeutics, Inc. (VYGR) announced the appointment of Toby Ferguson as Chief Medical Officer (CMO), ...

Voyager Therapeutics, Inc.: Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer

5d ago, source:

Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced the appointment ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...